Prekyba Evotec AG - EVT CFD
Pridėti prie mėgstamų- Santrauka
- Istoriniai duomenys
- Įvykiai
- Pajamų ataskaita
- Balansas
- Pinigų srautai
- Nuosavybė
Skirtumas | 0.100 | ||||||||
Ilgos pozicijos nakties mokestis
Long position overnight fee
Eiti į platformą | -0.019974% | ||||||||
Trumpos pozicijos nakties mokestis
Short position overnight fee
Eiti į platformą | -0.002248% | ||||||||
Nakties mokesčio laikas | 21:00 (UTC) | ||||||||
Mažiausias parduodamas kiekis | 1 | ||||||||
Valiuta | EUR | ||||||||
Marža | 20% | ||||||||
Akcijų birža | Germany | ||||||||
Prekybos mokesčiai | 0% |
*Information provided by Capital.com
Evotec SE ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Ankstesnis uždarymas* | 20.195 |
Atviras* | 20.115 |
1 metų pokytis* | -18.79% |
Dienos intervalas* | 19.935 - 20.415 |
52 savaičių intervalas | 14.80-29.71 |
Vidutinė apimtis (10 dienų) | 405.45K |
Vidutinė apimtis (3 mėn.) | 10.91M |
Rinkos kapitalizacija | 3.61B |
P/E santykis | -100.00K |
Neišpirktos akcijos | 176.94M |
Pajamos | 751.45M |
EPS | -0.99 |
Dividendai (pajamingumas %) | N/A |
Beta | 0.86 |
Kito pelno data | Aug 9, 2023 |
Visus duomenis pateikė Refinitiv, išskyrus žvaigždute pažymėtus duomenis, kurie yra Capital.com pateikti *duomenys
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Uždarymas | Change | Change (%) | Atidarymas | High | Low |
---|---|---|---|---|---|---|
May 26, 2023 | 20.345 | 0.150 | 0.74% | 20.195 | 20.435 | 19.895 |
May 25, 2023 | 20.195 | 0.285 | 1.43% | 19.910 | 20.585 | 19.825 |
May 24, 2023 | 19.900 | -0.165 | -0.82% | 20.065 | 20.235 | 19.780 |
May 23, 2023 | 20.175 | 0.480 | 2.44% | 19.695 | 20.675 | 19.695 |
May 22, 2023 | 19.900 | 0.240 | 1.22% | 19.660 | 19.930 | 19.390 |
May 19, 2023 | 19.720 | 0.365 | 1.89% | 19.355 | 19.815 | 19.265 |
May 18, 2023 | 19.265 | -0.320 | -1.63% | 19.585 | 19.740 | 19.205 |
May 17, 2023 | 19.475 | -0.710 | -3.52% | 20.185 | 20.195 | 19.275 |
May 16, 2023 | 20.325 | 0.550 | 2.78% | 19.775 | 20.595 | 19.730 |
May 15, 2023 | 19.785 | 0.535 | 2.78% | 19.250 | 20.105 | 19.220 |
May 12, 2023 | 18.835 | 0.315 | 1.70% | 18.520 | 19.075 | 18.385 |
May 11, 2023 | 18.665 | 0.120 | 0.65% | 18.545 | 19.520 | 18.460 |
May 10, 2023 | 18.655 | 1.665 | 9.80% | 16.990 | 18.920 | 16.920 |
May 9, 2023 | 16.355 | 0.000 | 0.00% | 16.355 | 16.605 | 16.030 |
May 8, 2023 | 16.375 | -0.670 | -3.93% | 17.045 | 17.205 | 15.860 |
May 5, 2023 | 16.970 | 0.500 | 3.04% | 16.470 | 16.985 | 15.300 |
May 4, 2023 | 17.090 | 0.440 | 2.64% | 16.650 | 17.125 | 16.520 |
May 3, 2023 | 16.670 | 0.010 | 0.06% | 16.660 | 16.810 | 16.215 |
May 2, 2023 | 16.720 | 0.065 | 0.39% | 16.655 | 16.925 | 16.620 |
Apr 28, 2023 | 16.570 | 0.130 | 0.79% | 16.440 | 16.660 | 16.210 |
Evotec AG Events
Laikas (UTC) (UTC) | Šalis | Įvykis |
---|---|---|
Monday, June 5, 2023 | ||
Laikas (UTC) (UTC) 10:59 | Šalis DE
| Įvykis Evotec SE Capital Markets Day Evotec SE Capital Markets DayForecast -Previous - |
Tuesday, June 20, 2023 | ||
Laikas (UTC) (UTC) 10:59 | Šalis DE
| Įvykis Evotec SE Annual Shareholders Meeting Evotec SE Annual Shareholders MeetingForecast -Previous - |
Wednesday, June 21, 2023 | ||
Laikas (UTC) (UTC) 10:59 | Šalis DE
| Įvykis Evotec SE at Deutsche Bank dbAccess German Corporate Conference Evotec SE at Deutsche Bank dbAccess German Corporate ConferenceForecast -Previous - |
Thursday, June 29, 2023 | ||
Laikas (UTC) (UTC) 10:59 | Šalis DE
| Įvykis Evotec SE Stifel Bordeaux Conference Evotec SE Stifel Bordeaux ConferenceForecast -Previous - |
Wednesday, August 9, 2023 | ||
Laikas (UTC) (UTC) 10:59 | Šalis DE
| Įvykis Q2 2023 Evotec SE Earnings Call Q2 2023 Evotec SE Earnings CallForecast -Previous - |
Wednesday, September 6, 2023 | ||
Laikas (UTC) (UTC) 10:59 | Šalis DE
| Įvykis Evotec SE Citi Annual BioPharma Conference Evotec SE Citi Annual BioPharma ConferenceForecast -Previous - |
Thursday, September 21, 2023 | ||
Laikas (UTC) (UTC) 10:59 | Šalis DE
| Įvykis Evotec SE at HC Wainwright Investment Conference Evotec SE at HC Wainwright Investment ConferenceForecast -Previous - |
- Metinis
- Kas ketvirtį
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Visos pajamos | 751.448 | 618.034 | 500.924 | 446.437 | 375.405 |
Pajamos | 751.448 | 618.034 | 500.924 | 446.437 | 375.405 |
Bendros pajamos, iš viso | 577.383 | 466.491 | 375.181 | 313.546 | 263.389 |
Pajamos | 174.065 | 151.543 | 125.743 | 132.891 | 112.016 |
Pajamų sąnaudos, iš viso | 724.824 | 588.901 | 452.368 | 383.843 | 297.942 |
Pardavimas / Bendrosios / administravimo išlaidos, iš viso | 156.19 | 105.445 | 77.205 | 66.546 | 57.012 |
Tyrimai ir plėtra | 76.642 | 72.2 | 63.945 | 58.432 | 35.619 |
Neįprastos išlaidos (pajamos) | -5.774 | 12.546 | 3.244 | 11.919 | -11.036 |
Other Operating Expenses, Total | -79.617 | -67.781 | -67.207 | -66.6 | -47.042 |
Veiklos pajamos | 26.624 | 29.133 | 48.556 | 62.594 | 77.463 |
Palūkanų pajamos (išlaidos), grynosios ne veiklos pajamos | -179.854 | 208.106 | -22.925 | -6.102 | -5.602 |
Kita, pajamos | -0.727 | -0.259 | 0.209 | 0.07 | 0.138 |
Grynosios pajamos prieš mokesčius | -153.957 | 236.98 | 25.84 | 56.562 | 71.999 |
Grynosios pajamos po mokesčių | -175.655 | 215.51 | 6.278 | 37.228 | 84.056 |
Mažumos palūkanos | 0 | 0 | 0 | 0.844 | 0.116 |
Grynosios pajamos prieš papildomas. Prekės | -175.655 | 215.51 | 6.278 | 38.072 | 84.172 |
Grynosios pajamos | -175.655 | 215.51 | 6.278 | 38.072 | 84.172 |
Pajamos, kurias galima gauti bendrai, išskyrus papildomas pajamas. Prekės | -175.655 | 215.51 | 6.278 | 38.072 | 84.172 |
Pajamos, kurias galima gauti bendrai, įskaitant papildomas pajamas. Prekės | -175.655 | 215.51 | 6.278 | 38.072 | 84.172 |
Skiedžiamas grynasis pelnas | -175.655 | 215.51 | 6.278 | 38.072 | 84.172 |
Skiedžiamas svertinis vidutinis akcijų skaičius | 176.674 | 166.406 | 153.752 | 149.726 | 147.482 |
Skiedžiamas pelnas už akcijas, neįskaitant ypatingų prekių | -0.99423 | 1.29509 | 0.04083 | 0.25428 | 0.57073 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | 0 |
Skiedžiamas normalizuotas pelnas, gautas iš pelno | -1.01547 | 1.36365 | 0.05455 | 0.30667 | 0.52209 |
Skiedimo koregavimas | 0 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Visos pajamos | 240.689 | 173.884 | 172.203 | 164.672 | 187.071 |
Pajamos | 240.689 | 173.884 | 172.203 | 164.672 | 187.071 |
Bendros pajamos, iš viso | 158.233 | 145.464 | 141.308 | 132.378 | 134.997 |
Pajamos | 82.456 | 28.42 | 30.895 | 32.294 | 52.074 |
Pajamų sąnaudos, iš viso | 197.229 | 187.413 | 175.973 | 164.209 | 179.5 |
Pardavimas / Bendrosios / administravimo išlaidos, iš viso | 46.332 | 42.462 | 35.83 | 31.566 | 34.408 |
Tyrimai ir plėtra | 21.322 | 18.482 | 18.725 | 18.113 | 18.728 |
Other Operating Expenses, Total | -22.884 | -18.995 | -19.89 | -17.848 | -16.005 |
Veiklos pajamos | 43.46 | -13.529 | -3.77 | 0.463 | 7.571 |
Palūkanų pajamos (išlaidos), grynosios ne veiklos pajamos | -60.362 | -29.806 | -20.131 | -69.555 | -25.191 |
Kita, pajamos | -0.622 | -0.029 | -0.435 | 0.359 | -0.216 |
Grynosios pajamos prieš mokesčius | -17.524 | -43.364 | -24.336 | -68.733 | -17.836 |
Grynosios pajamos po mokesčių | -27.201 | -47.275 | -27.937 | -73.242 | -31.478 |
Grynosios pajamos prieš papildomas. Prekės | -27.201 | -47.275 | -27.937 | -73.242 | -31.478 |
Grynosios pajamos | -27.201 | -47.275 | -27.937 | -73.242 | -31.478 |
Pajamos, kurias galima gauti bendrai, išskyrus papildomas pajamas. Prekės | -27.201 | -47.275 | -27.937 | -73.242 | -31.478 |
Pajamos, kurias galima gauti bendrai, įskaitant papildomas pajamas. Prekės | -27.201 | -47.275 | -27.937 | -73.242 | -31.478 |
Skiedžiamas grynasis pelnas | -27.201 | -47.275 | -27.937 | -73.242 | -31.478 |
Skiedžiamas svertinis vidutinis akcijų skaičius | 176.589 | 176.703 | 176.703 | 176.703 | 172.677 |
Skiedžiamas pelnas už akcijas, neįskaitant ypatingų prekių | -0.15404 | -0.26754 | -0.1581 | -0.41449 | -0.18229 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | 0 |
Skiedžiamas normalizuotas pelnas, gautas iš pelno | -0.17529 | -0.26754 | -0.1581 | -0.41449 | -0.15454 |
Neįprastos išlaidos (pajamos) | -5.774 | 0 | 0 | 7.372 | |
Mažumos palūkanos | 0 | 0 |
- Metinis
- Kas ketvirtį
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Trumpalaikis turtas iš viso | 1073.67 | 1100.94 | 658.844 | 469.53 | 249.769 |
Pinigai ir trumpalaikės investicijos | 729.983 | 858.498 | 492.634 | 321.662 | 149.879 |
Pinigai ir ekvivalentai | 415.155 | 699.326 | 422.58 | 277.034 | 109.055 |
Trumpalaikės investicijos | 314.828 | 159.172 | 70.054 | 44.628 | 40.824 |
Gautinos sumos, iš viso, grynąja verte | 256.737 | 176.754 | 122.221 | 117.844 | 74.772 |
Accounts Receivable - Trade, Net | 199.169 | 150.692 | 91.612 | 93.702 | 58.851 |
Total Inventory | 29.825 | 25.793 | 13.585 | 10.749 | 5.66 |
Prepaid Expenses | 40.178 | 19.21 | 9.258 | 9.166 | 8.451 |
Other Current Assets, Total | 16.948 | 20.685 | 21.146 | 10.109 | 11.007 |
Total Assets | 2257.25 | 2235.16 | 1462.34 | 1180.91 | 771.883 |
Property/Plant/Equipment, Total - Net | 650.201 | 484.597 | 337.297 | 239.229 | 90.519 |
Property/Plant/Equipment, Total - Gross | 920.81 | 686.086 | 481.879 | 350.415 | 164.143 |
Accumulated Depreciation, Total | -270.609 | -201.489 | -144.582 | -111.186 | -73.624 |
Goodwill, Net | 274.819 | 257.569 | 247.37 | 255.919 | 220.791 |
Intangibles, Net | 23.819 | 30.851 | 98.036 | 116.994 | 122.989 |
Long Term Investments | 150.332 | 287.009 | 59.021 | 41.252 | 28.99 |
Note Receivable - Long Term | 70.293 | 55.966 | 36.485 | 22.718 | 14.601 |
Other Long Term Assets, Total | 14.112 | 18.229 | 25.284 | 35.27 | 44.224 |
Total Current Liabilities | 337.706 | 324.516 | 208.459 | 178.955 | 196.275 |
Accounts Payable | 97.277 | 72.598 | 42.549 | 31.319 | 31.137 |
Accrued Expenses | 47.49 | 33.983 | 34.728 | 29.174 | 25.67 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 16.381 | 50.609 | 30.008 | 20.731 | 56.919 |
Other Current Liabilities, Total | 176.558 | 167.326 | 101.174 | 97.731 | 82.549 |
Total Liabilities | 1070.06 | 857.476 | 737.881 | 703.883 | 347.879 |
Total Long Term Debt | 490.293 | 462.308 | 461.957 | 442.368 | 57.546 |
Long Term Debt | 328.295 | 326.344 | 331.019 | 324.886 | 54.68 |
Capital Lease Obligations | 161.998 | 135.964 | 130.938 | 117.482 | 2.866 |
Deferred Income Tax | 18.524 | 17.688 | 20.399 | 21.199 | 21.517 |
Minority Interest | 0 | 0 | 0 | 0 | 0.876 |
Other Liabilities, Total | 223.54 | 52.964 | 47.066 | 61.361 | 71.665 |
Total Equity | 1187.18 | 1377.69 | 724.456 | 477.029 | 424.004 |
Common Stock | 176.953 | 176.608 | 163.915 | 150.903 | 149.063 |
Additional Paid-In Capital | 1440.01 | 1430.14 | 1030.7 | 786.865 | 783.154 |
Retained Earnings (Accumulated Deficit) | -392.377 | -216.421 | -432.639 | -441.177 | -481.013 |
Unrealized Gain (Loss) | -21.113 | 3.053 | 4.26 | 4.565 | 6.002 |
Other Equity, Total | -16.289 | -15.691 | -41.782 | -24.127 | -33.202 |
Total Liabilities & Shareholders’ Equity | 2257.25 | 2235.16 | 1462.34 | 1180.91 | 771.883 |
Total Common Shares Outstanding | 176.703 | 176.358 | 163.665 | 150.653 | 148.813 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Trumpalaikis turtas iš viso | 1073.67 | 1095.82 | 1144.46 | 1061.51 | 1100.94 |
Pinigai ir trumpalaikės investicijos | 729.983 | 828.795 | 890.896 | 855.045 | 858.498 |
Pinigai ir ekvivalentai | 415.155 | 463.913 | 696.992 | 660.488 | 699.326 |
Trumpalaikės investicijos | 314.828 | 364.882 | 193.904 | 194.557 | 159.172 |
Gautinos sumos, iš viso, grynąja verte | 256.737 | 187.997 | 149.836 | 134.019 | 176.754 |
Accounts Receivable - Trade, Net | 199.169 | 140.631 | 126.688 | 112.617 | 150.692 |
Total Inventory | 29.825 | 30.874 | 28.995 | 26.076 | 25.793 |
Prepaid Expenses | 57.126 | 48.15 | 74.738 | 46.373 | 39.895 |
Total Assets | 2257.25 | 2262.66 | 2293.72 | 2185.02 | 2235.16 |
Property/Plant/Equipment, Total - Net | 650.201 | 600.499 | 559.531 | 521.357 | 484.597 |
Goodwill, Net | 274.819 | 278.417 | 259.003 | 257.649 | 257.569 |
Intangibles, Net | 23.819 | 25.736 | 26.985 | 29.157 | 30.851 |
Long Term Investments | 150.332 | 189.245 | 217.159 | 236.624 | 287.009 |
Note Receivable - Long Term | 70.293 | 56.911 | 67.225 | 61.595 | 55.966 |
Other Long Term Assets, Total | 14.112 | 16.039 | 19.347 | 17.128 | 18.229 |
Total Current Liabilities | 337.706 | 340.802 | 320.556 | 339.62 | 324.516 |
Accounts Payable | 97.277 | 83.965 | 80.893 | 74.739 | 72.598 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 16.381 | 14.108 | 14.382 | 50.641 | 50.609 |
Other Current Liabilities, Total | 224.048 | 242.729 | 225.281 | 214.24 | 201.309 |
Total Liabilities | 1070.06 | 1034.14 | 1018.18 | 875.162 | 857.476 |
Total Long Term Debt | 490.293 | 477.984 | 468.746 | 467.926 | 462.308 |
Long Term Debt | 328.295 | 326.776 | 325.888 | 326.116 | 326.344 |
Capital Lease Obligations | 161.998 | 151.208 | 142.858 | 141.81 | 135.964 |
Deferred Income Tax | 18.524 | 17.179 | 17.423 | 17.552 | 17.688 |
Other Liabilities, Total | 223.54 | 198.173 | 211.451 | 50.064 | 52.964 |
Total Equity | 1187.18 | 1228.53 | 1275.54 | 1309.86 | 1377.69 |
Common Stock | 176.953 | 176.953 | 176.953 | 176.953 | 176.608 |
Additional Paid-In Capital | 1440.01 | 1437.55 | 1435.3 | 1432.45 | 1430.14 |
Retained Earnings (Accumulated Deficit) | -392.377 | -364.631 | -317.356 | -289.629 | -216.421 |
Other Equity, Total | -16.289 | -21.348 | -5.327 | -9.912 | -15.691 |
Total Liabilities & Shareholders’ Equity | 2257.25 | 2262.66 | 2293.72 | 2185.02 | 2235.16 |
Total Common Shares Outstanding | 176.703 | 176.703 | 176.703 | 176.703 | 176.358 |
Unrealized Gain (Loss) | -21.113 | -14.032 | 3.053 | ||
Minority Interest | 0 | 0 | 0 | 0 | |
Other Current Assets, Total | 0.001 |
- Metinis
- Kas ketvirtį
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Grynosios pajamos / pradinė eilutė | -175.655 | 215.51 | 6.252 | 37.228 | 84.056 |
Pagrindinės veiklos pinigai | 203.106 | 122.237 | 44.721 | 42.216 | 156.24 |
Pagrindinės veiklos pinigai | 72.677 | 55.596 | 42.122 | 36.456 | 19.288 |
Amortization | 8.982 | 12.012 | 13.936 | 12.349 | 12.005 |
Deferred Taxes | 7.722 | 5.066 | 7.49 | 6.706 | -26.117 |
Nepiniginės prekės | 195.391 | -165.371 | 23.865 | 24.342 | 0.364 |
Cash Taxes Paid | 18.5 | -6.028 | 9.796 | 2.417 | 3.596 |
Sumokėtos palūkanos grynaisiais pinigais | 9.798 | 5.429 | 3.465 | 4.49 | 2.279 |
Apyvartinio kapitalo pokyčiai | 93.989 | -0.576 | -48.944 | -74.865 | 66.644 |
Investicinės veiklos pinigai | -415.823 | -243.855 | -155.089 | -86.634 | -39.13 |
Kapitalo išlaidos | -181.354 | -118.943 | -99.072 | -31.905 | -27.867 |
Kiti investiciniai pinigų srautų iš prekių, iš viso | -234.469 | -124.912 | -56.017 | -54.729 | -11.263 |
Finansinės veiklos pinigai | -52.414 | 398.43 | 246.409 | 211.263 | -77.764 |
Finansavimo pinigų srautų prekės | |||||
Akcijų išleidimas (išpirkimas), grynasis | 0.699 | 404.322 | 251.564 | 1.901 | 1.578 |
Skolos išleidimas (padengimas), grynasis | -53.113 | -5.892 | -5.155 | 209.362 | -79.342 |
Užsienio valiutos keitimo įtaka | -19.04 | -0.066 | 9.505 | 1.134 | 2.692 |
Grynasis pinigų pokytis | -284.171 | 276.746 | 145.546 | 167.979 | 42.038 |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -175.655 | -148.454 | -101.179 | -73.242 | 215.51 |
Cash From Operating Activities | 203.106 | 236.633 | 240.607 | 63.618 | 122.237 |
Changes in Working Capital | 378.761 | 385.087 | 341.786 | 136.86 | -93.273 |
Cash From Investing Activities | -415.823 | -435.034 | -206.857 | -95.732 | -243.855 |
Capital Expenditures | -181.354 | -157.21 | -81.371 | -42.921 | -118.943 |
Other Investing Cash Flow Items, Total | -234.469 | -277.824 | -125.486 | -52.811 | -124.912 |
Cash From Financing Activities | -52.414 | -50.454 | -45.805 | -5.279 | 398.43 |
Issuance (Retirement) of Stock, Net | 0.699 | 0.355 | 0.7 | 0.345 | 404.322 |
Issuance (Retirement) of Debt, Net | -53.113 | -50.809 | -46.505 | -5.624 | -5.892 |
Foreign Exchange Effects | -19.04 | 13.442 | 9.721 | -1.445 | -0.066 |
Net Change in Cash | -284.171 | -235.413 | -2.334 | -38.838 | 276.746 |
Investuotojo pavadinimas | Investuotojo tipas | Apyvartoje esantis procentas | Turimos akcijos | Turimų akcijų pokytis | Turėjimo data | Apyvartos vertinimas |
---|---|---|---|---|---|---|
Novo Holdings A/S | Venture Capital | 9.8455 | 17444807 | -206374 | 2022-12-31 | LOW |
Mubadala Investment Company PJSC | Sovereign Wealth Fund | 6.9908 | 12386686 | 905184 | 2022-10-31 | LOW |
Government of Abu Dhabi | Government Agency | 6.4788 | 11479533 | 1602555 | 2021-12-31 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 5.0223 | 8898869 | 41673 | 2023-05-08 | LOW |
Allianz Global Investors GmbH | Investment Advisor | 2.9667 | 5256528 | -2846371 | 2022-01-07 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.5292 | 4481409 | 22337 | 2023-04-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.2224 | 3937850 | 851779 | 2022-12-31 | LOW |
BlackRock Asset Management Deutschland AG | Investment Advisor | 2.1806 | 3863645 | -2640906 | 2023-05-08 | LOW |
Brown Capital Management, LLC | Investment Advisor | 2.165 | 3836114 | -24213 | 2022-09-30 | LOW |
Liontrust Investment Partners LLP | Investment Advisor | 2.1387 | 3789407 | -30493 | 2023-03-31 | LOW |
Oetker (Roland) | Individual Investor | 1.639 | 2904146 | -5440854 | 2022-10-04 | |
Franklin Equity Group | Investment Advisor | 1.4392 | 2550000 | 0 | 2023-04-30 | LOW |
DWS Investment GmbH | Investment Advisor/Hedge Fund | 1.2375 | 2192705 | -7801 | 2023-03-31 | LOW |
Polar Capital LLP | Investment Advisor/Hedge Fund | 1.1488 | 2035438 | 241875 | 2023-03-31 | LOW |
California State Teachers Retirement System | Pension Fund | 1.0986 | 1946619 | 1704482 | 2022-06-30 | LOW |
Deka Investment GmbH | Investment Advisor/Hedge Fund | 1.0342 | 1832515 | 4436 | 2023-04-30 | LOW |
Evotec SE Management | Corporation | 0.9987 | 1769527 | 356661 | 2022-10-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.9836 | 1742828 | -20314 | 2023-04-30 | LOW |
Lanthaler (Werner) | Individual Investor | 0.8196 | 1452188 | 340452 | 2021-09-30 | LOW |
Baillie Gifford & Co. | Investment Advisor | 0.8023 | 1421555 | -27576 | 2023-03-31 | LOW |
Kodėl Capital.com? Mūsų skaičiai kalba už save.
Capital.com Group530K+
Prekeiviai
87K+
Aktyvūs klientai kas mėnesį
$46M+
Mėnesio investicijų apimtis
$31M+
Atsiimama kas mėnesį
Prekybos skaičiuoklė
Apskaičiuokite savo hipotetinį pelną ir pelną, jei CFD sandorį atidarėte tam tikrą dieną (pasirinkite datą) ir uždarėte kitą dieną (pasirinkite datą).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Evotec Company profile
Apie Evotec AG
"Evotec SE" yra Vokietijoje įsikūrusi vaistų paieškos ir kūrimo bendrovė. Įmonė užsiima naujų farmacijos produktų kūrimu, sudarydama mokslinių tyrimų aljansus ir plėtodama partnerystę su farmacijos ir biotechnologijų bendrovėmis, akademinėmis institucijomis, pacientų organizacijomis ir rizikos kapitalo bendrovėmis. Vaistų atradimo sprendimai teikiami mokamų paslaugų, integruotų vaistų atradimo aljansų, plėtros partnerysčių, kandidatų į vaistus licencijavimo ir konsultacinių susitarimų forma. Įmonė "Evotec SE" veikia įvairiose srityse, įskaitant neurologiją, diabetą ir diabeto komplikacijas, skausmą ir uždegimą, onkologiją, infekcines ligas, kvėpavimo takų ligas ir fibrozę. Jos ruošiami vaistai apima įvairias terapines sritis, pavyzdžiui, CNS nemigą, lėtinį kosulį, imunologiją ir uždegimą, moterų sveikatos endometriozę, nefrologiją, dermatologines ligas, fibrozines ligas, antivirusines ligas ir kt.
Industry: | Biotechnology & Medical Research (NEC) |
Essener Bogen 7
HAMBURG
HAMBURG 22419
DE
Pajamų ataskaita
- Annual
- Quarterly
Žmonės taip pat žiūri
Vis dar ieškote brokerio kuriuo galėtumėte pasitikėti?
Prisijunkite prie 530 000+ prekeivių visame pasaulyje, kurie pasirinko prekybą su Capital.com